<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05003011</url>
  </required_header>
  <id_info>
    <org_study_id>CRD-02-1511</org_study_id>
    <nct_id>NCT05003011</nct_id>
  </id_info>
  <brief_title>Correlation of Hemodynamics Via Pulmonary Artery Catherization and the Cardiospire</brief_title>
  <official_title>Correlation of Hemodynamics Via Pulmonary Artery Catherization and the Cardiospire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Respirix, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Respirix, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as an observational study to collect Cardiospire cardiogenic&#xD;
      oscillation signal (COS) and CO output parameters from the Pulmonary Artery Catheter in&#xD;
      intubated patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Respirix has developed a non-invasive hemodynamic monitoring device called the Cardiospire.&#xD;
      The Cardiospire detects minor, cyclic waveforms caused by Cardiogenic Oscillations (COS) and&#xD;
      uses features of the COS waveform to provide information about hemodynamics.&#xD;
&#xD;
      This study is designed as an observational study to collect paired readings of the&#xD;
      Cardiospire cardiogenic oscillation signal (COS) and the ground truth CO output parameters,&#xD;
      including Pulmonary Artery Pressure diastolic (PAPd), systolic (PAPs), Stroke Volume (SV),&#xD;
      and Cardiac Output (CO) from the Pulmonary Artery Catheter in intubated patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 15, 2021</start_date>
  <completion_date type="Anticipated">September 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Repeatable Data Verification</measure>
    <time_frame>3 months</time_frame>
    <description>First 10 patient Cardiospire data will be processed and analyzed to determine if deemed repeatable for cardiogenic oscillations (COS).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation and Validation of data</measure>
    <time_frame>1.5 years</time_frame>
    <description>Collected Cardiospire data from next 150 patients will be analyzed in comparison to PAC data for correlation and validation purposes.</description>
  </primary_outcome>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Hemodynamic Instability</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiospire</intervention_name>
    <description>Non-invasive hemodynamic monitoring</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Intubated patients in the ICU&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â‰¥ 18 years of age&#xD;
&#xD;
          -  Intubated&#xD;
&#xD;
          -  Pulmonary artery catheter&#xD;
&#xD;
          -  Patient or patient's legally authorized representative is able to provide informed&#xD;
             consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects who, at the principal investigator's determination, would not be appropriate&#xD;
             for this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Carin Lindquist</last_name>
    <phone>4159268616</phone>
    <email>clindquist@theranova.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Kamal Gupta, MD</last_name>
      <phone>913-588-1227</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 6, 2021</study_first_submitted>
  <study_first_submitted_qc>August 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

